optibright® Unique combination product for the maintenance of a natural tear fluid production
optibright® combines the efficacies of branded maqui berry extract MaquiBright® and DHA-rich omega-3 oil for a remarkable double action on tear fluid management.
MaquiBright® is standardised to bear a minimum of 25% delphinidins and a minimum of 35% total anthocyanins. The extract supports aqueous tear fluid production in lacrimal glands by eliminating free radicals and reactive oxygen species, as proven in pre-clinical and clinical studies.
Our omega-3 oil contains 50% docosahexaenoic acid (DHA*) and 20% eicosapentaenoic acid (EPA). The oil supports lipid layer synthesis in meibomian glands – required for evaporation protection and for stabilisation of tear film.
*EFSA Health Claim: DHA contributes to the maintenance of normal vision.
| Market Application | Details | References |
| Tear-fluid management | MaquiBright® supports aqueous tear fluid production in lacrimal glands by eliminating free radicals and reactive oxygen species | Hitoe et al., 2014 Nakamura et al., 2014 |
| Omega-3 Oil supports lipid layer synthesis in meibomian glands – required for evaporation protection and for stabilisation of tear film. | Bhargava et al., 2013 Deinema et al., 2017 Bhargava et al., 2016 |
|
| DHA contributes to the maintenance of normal vision. | EFSA Journal 2010;8(10):1734. [27 pp.] |
